Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3793154, 7 pages
https://doi.org/10.1155/2018/3793154
Review Article

Searching for Clinically Relevant Biomarkers in Geriatric Oncology

1Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece
2Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE
3Department of Radiation Oncology, University of Patras Medical School, Patras, Greece

Correspondence should be addressed to Theodora Katsila; rg.sartapu@alistakht

Received 23 August 2017; Accepted 15 January 2018; Published 18 February 2018

Academic Editor: Nam Nguyen

Copyright © 2018 Theodora Katsila et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Balducci and M. Extermann, “Management of cancer in the older person: A practical approach,” The Oncologist, vol. 5, no. 3, pp. 224–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at Publisher · View at Google Scholar · View at Scopus
  3. E. R. Stadtman, “Protein oxidation and aging,” Science, vol. 257, no. 5074, pp. 1220–1224, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. R. S. Balaban, S. Nemoto, and T. Finkel, “Mitochondria, oxidants, and aging,” Cell, vol. 120, no. 4, pp. 483–495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. V. Blagosklonny and M. N. Hall, “Growth and aging: a common molecular mechanism,” Aging, vol. 1, no. 4, pp. 357–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. de La Fuente and J. Miquel, “An update of the oxidation-inflammation theory of aging: the involvement of the immune system in Oxi-Inflamm-Aging,” Current Pharmaceutical Design, vol. 15, no. 26, pp. 3003–3026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Pawelec, A. Larbi, and E. Derhovanessian, “Senescence of the Human Immune System,” Journal of Comparative Pathology, vol. 142, no. 1, pp. S39–S44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Franceschi, M. Bonafè, S. Valensin et al., “Inflamm-aging. An evolutionary perspective on immunosenescence,” Annals of the New York Academy of Sciences, vol. 908, pp. 244–254, 2000. View at Google Scholar · View at Scopus
  9. D. Baylis, D. B. Bartlett, H. P. Patel, and H. C. Roberts, “Understanding how we age: insights into inflammaging,” Longevity & Healthspan, vol. 2, no. 1, article 8, 2013. View at Publisher · View at Google Scholar
  10. C. Franceschi and J. Campisi, “Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 69, suppl. 1, pp. s4–s9, 2014. View at Publisher · View at Google Scholar
  11. J. Wang, H. Geiger, and K. L. Rudolph, “Immunoaging induced by hematopoietic stem cell aging,” Current Opinion in Immunology, vol. 23, no. 4, pp. 532–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wang, Q. Sun, Y. Morita et al., “A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage,” Cell, vol. 148, no. 5, pp. 1001–1014, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Song, J. Wang, L. M. Guachalla et al., “Alterations of the systemic environment are the primary cause of impaired B and T lymphopoiesis in telomere-dysfunctional mice,” Blood, vol. 115, no. 8, pp. 1481–1489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Song, J. Zhang, Z. Ju, and K. L. Rudolph, “Telomere dysfunctional environment induces loss of quiescence and inherent impairments of hematopoietic stem cell function,” Aging Cell, vol. 11, no. 3, pp. 449–455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Von Figura, D. Hartmann, Z. Song, and K. L. Rudolph, “Role of telomere dysfunction in aging and its detection by biomarkers,” Journal of Molecular Medicine, vol. 87, no. 12, pp. 1165–1171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Marrone and P. M. Forde, “Cancer immunotherapy in older patients,” Cancer Journal (United States), vol. 23, no. 4, pp. 219–222, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Levine, “Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age?” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 68, no. 6, pp. 667–674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Singh and B. Bajorek, “Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy,” Pharmacy Practice, vol. 12, no. 4, article no. 489, 2014. View at Google Scholar · View at Scopus
  19. A. J. McLean and D. G. le Couteur, “Aging biology and geriatric clinical pharmacology,” Pharmacological Reviews, vol. 56, no. 2, pp. 163–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Orimo, H. Ito, T. Suzuki, and M. Sawabe, “Reviewing the definition of “elderly”,” Geriatrics & Gerontology International, vol. 6, no. 3, pp. 149–158, 2006. View at Google Scholar
  21. C. Falandry, E. Gilson, and K. L. Rudolph, “Are aging biomarkers clinically relevant in oncogeriatrics?” Critical Review in Oncology/Hematology, vol. 85, no. 3, pp. 257–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Lee, K. Lindquist, M. R. Segal et al., “Development and Validation of a Prognostic Index for 4-Year Mortality in Older Adults,” Journal of the American Medical Association, vol. 295, no. 7, pp. 801–808, 2006. View at Publisher · View at Google Scholar
  23. L. C. Yourman, S. J. Lee, M. A. Schonberg, E. W. Widera, and A. K. Smith, “Prognostic indices for older adults: A systematic review,” Journal of the American Medical Association, vol. 307, no. 2, pp. 182–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Lee, W. Shin, B. Kim et al., “HiPub: Translating PubMed and PMC texts to networks for knowledge discovery,” Bioinformatics, vol. 32, no. 18, pp. 2886–2888, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Falandry, M. Bonnefoy, G. Freyer, and E. Gilson, “Biology of cancer and aging: A complex association with cellular senescence,” Journal of Clinical Oncology, vol. 32, no. 24, pp. 2604–2610, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. B. Sieburg, R. H. Cho, B. Dykstra, N. Uchida, C. J. Eaves, and C. E. Muller-Sieburg, “The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets,” Blood, vol. 107, no. 6, pp. 2311–2316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Goto, “Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory?” Bioscience Trends, vol. 2, no. 6, pp. 218–230, 2008. View at Google Scholar · View at Scopus
  28. A. Salminen, K. Kaarniranta, and A. Kauppinen, “Inflammaging: disturbed interplay between autophagy and inflammasomes,” AGING, vol. 4, no. 3, pp. 166–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Giovannini, G. Onder, R. Liperoti et al., “Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals,” Journal of the American Geriatrics Society, vol. 59, no. 9, pp. 1679–1685, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Salvioli, D. Monti, C. Lanzarini et al., “Immune system, cell senescence, aging and longevity - inflamm-aging reappraised,” Current Pharmaceutical Design, vol. 19, no. 9, pp. 1675–1679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Monti, R. Ostan, V. Borelli, G. Castellani, and C. Franceschi, “Inflammaging and human longevity in the omics era,” Mechanisms of Ageing and Development, vol. 165, pp. 129–138, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Hubbard, H. J. Cohen, and H. B. Muss, “Incorporating biomarkers into cancer and aging research,” Journal of Clinical Oncology, vol. 32, no. 24, pp. 2611–2616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Wadhwa, Z. Kaul, and S. C. Kaul, “Cell Cycle Checkpoints and Senescence,” in Cellular Ageing and Replicative Senescence, Healthy Ageing and Longevity, pp. 145–167, Springer International Publishing, Cham, Germany, 2016. View at Publisher · View at Google Scholar
  34. J.-P. Coppé, C. K. Patil, F. Rodier et al., “Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor,” PLoS Biology, vol. 6, no. 12, article e301, pp. 2853–2868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. C. Kowdley, N. Merchant, J. P. Richardson, J. Somerville, M. Gorospe, and S. C. Cunningham, “Cancer surgery in the elderly,” The Scientific World Journal, vol. 2012, Article ID 303852, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Ju, H. Jiang, M. Jaworski et al., “Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment,” Nature Medicine, vol. 13, no. 6, pp. 742–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Falandry, B. Horard, A. Bruyas et al., “Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: A multicenter GINECO study,” AGING, vol. 7, no. 12, pp. 1066–1076, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Li, N. A. de Glas, and A. Hurria, “Cancer and Aging: General Principles, Biology, and Geriatric Assessment.,” Clinics in Geriatric Medicine, vol. 32, no. 1, pp. 1–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. P. K. Prasad, L. B. Signorello, D. L. Friedman, J. D. Boice, and E. Pukkala, “Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland,” Pediatric Blood & Cancer, vol. 58, no. 3, pp. 421–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Hammerlid and C. Taft, “Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms,” British Journal of Cancer, vol. 84, no. 2, pp. 149–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Cella, J.-S. Lai, C.-H. Chang, A. Peterman, and M. Slavin, “Fatigue in cancer patients compared with fatigue in the general United States population,” Cancer, vol. 94, no. 2, pp. 528–538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. R. A. DePinho, “The age of cancer,” Nature, vol. 408, no. 6809, pp. 248–254, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Meucci, U. Keilholz, I. Tinhofer, and O. A. Ebner, “Mutational load and mutational patterns in relation to age in head and neck cancer,” Oncotarget , vol. 7, no. 43, pp. 69188–69199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Talarico, G. Chen, and R. Pazdur, “Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration,” Journal of Clinical Oncology, vol. 22, no. 22, pp. 4626–4631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J. K. Bailur, G. Pawelec, S. Hatse et al., “Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty,” Breast cancer research: BCR, vol. 19, no. 1, article 20, 2017. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Brouwers, B. Dalmasso, S. Hatse et al., “Biological ageing and frailty markers in breast cancer patients,” AGING, vol. 7, no. 5, pp. 319–333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Soubeyran, C. Bellera, J. Goyard et al., “Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project,” Journal of Clinical Oncology, vol. 29, suppl. 15, pp. 9001–9001, 2011. View at Publisher · View at Google Scholar
  48. S. Hatse, B. Brouwers, B. Dalmasso et al., “Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status,” PLoS ONE, vol. 9, no. 10, article e110644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. K. S. Hughes, E. P. Ambinder, G. P. Hess et al., “Identifying health information technology needs of oncologists to facilitate the adoption of genomic medicine: Recommendations from the 2016 American society of clinical oncology omics and precision Oncology workshop,” Journal of Clinical Oncology, vol. 35, no. 27, pp. 3153–3159, 2017. View at Publisher · View at Google Scholar · View at Scopus
  50. J.-E. Kurtz, D. Heitz, V. Kurtz-Illig, and P. Dufour, “Geriatric oncology: How far have we gone and what are the next steps?” Oncology, vol. 77, no. 3-4, pp. 147–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. J.-E. Kurtz, D. Heitz, P. Enderlin et al., “Geriatric oncology, general practitioners and specialists: Current opinions and unmet needs,” Critical Review in Oncology/Hematology, vol. 75, no. 1, pp. 47–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Spyropoulou, A. G. Pallis, M. Leotsinidis, and D. Kardamakis, “Completion of radiotherapy is associated with the Vulnerable Elders Survey-13 score in elderly patients with cancer,” Journal of Geriatric Oncology, vol. 5, no. 1, pp. 20–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Saliba, M. Elliott, L. Z. Rubenstein et al., “The vulnerable elders survey: a tool for identifying vulnerable older people in the community,” Journal of the American Geriatrics Society, vol. 49, no. 12, pp. 1691–1699, 2001. View at Publisher · View at Google Scholar
  54. M. Vallet-Regí, M. Manzano, L. Rodriguez-Mañas, M. C. López, M. Aapro, and L. Balducci, “Management of cancer in the older age person: An approach to complex medical decisions,” The Oncologist, vol. 22, no. 3, pp. 335–342, 2017. View at Publisher · View at Google Scholar · View at Scopus
  55. M. G. Huisman, M. Kok, G. H. de Bock, and B. L. van Leeuwen, “Delivering tailored surgery to older cancer patients: Preoperative geriatric assessment domains and screening tools – A systematic review of systematic reviews,” European Journal of Surgical Oncology, vol. 43, no. 1, pp. 1–14, 2017. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Hurria, L. Jones, and H. B. Muss, “Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions,” American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, vol. 35, pp. e516–e522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. M. M. Kemeny, B. L. Peterson, A. B. Kornblith et al., “Barriers to clinical trial participation by older women with breast cancer,” Journal of Clinical Oncology, vol. 21, no. 12, pp. 2268–2275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. V. H. Murthy, H. M. Krumholz, and C. P. Gross, “Participation in cancer clinical trials: Race-, sex-, and age-based disparities,” Journal of the American Medical Association, vol. 291, no. 22, pp. 2720–2726, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. U. Basso, S. Tonti, C. Bassi et al., “Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program,” Critical Review in Oncology/Hematology, vol. 66, no. 2, pp. 163–170, 2008. View at Publisher · View at Google Scholar · View at Scopus